Best Selling Pharmaceutical Drugs in 2021
Report Scope:
This research report incorporates an in-depth analysis of the pharmaceutical drugs market and its competitive landscape through 2021. Major players, competitive intelligence, innovative technologies, and company profiles are discussed in detail. The report also examines recent developments and product portfolios of major players, and it features market share analysis and rankings in the market. It includes a regulatory landscape analysis that focuses on recent regulations in regions such as the U.S., Europe, and Japan.
Report Includes:
This research report incorporates an in-depth analysis of the pharmaceutical drugs market and its competitive landscape through 2021. Major players, competitive intelligence, innovative technologies, and company profiles are discussed in detail. The report also examines recent developments and product portfolios of major players, and it features market share analysis and rankings in the market. It includes a regulatory landscape analysis that focuses on recent regulations in regions such as the U.S., Europe, and Japan.
Report Includes:
- An overview of the best-selling pharmaceutical drugs in 2021
- Revenue forecast of the top 50 pharmaceutical drugs and assessment of their regulatory landscape
- Description of the pharmaceutical drugs applications and information on pharmaceutical drugs patents
- Detailed company profiles of the top 50 pharmaceutical drugs
CHAPTER 1 INTRODUCTION
1.1 Study Goals and Objectives
1.2 Reasons for Doing This Study
1.3 Scope of Report
1.4 Methodology
1.4.1 Primary Data and Information Gathering
1.4.2 Secondary Data and Information Gathering
1.4.3 Market Revenue Forecasts
1.5 Analyst's Credentials
1.6 BCC Custom Research
1.7 Related BCC Research Reports
CHAPTER 2 GLOBAL PHARMACEUTICAL DRUG MARKET
2.1 Overview
2.2 Key Strategies of Major Pharmaceutical Drugs Manufacturers
2.2.1 Distribution Network
2.2.2 Trends
2.2.3 Mergers and Acquisitions
2.2.4 Recommendations
2.3 Key Developments of the Major Pharmaceutical Drugs Manufacturers
2.3.1 Mergers and Acquisitions
2.3.2 Agreements, Joint Ventures, Expansions, Divestments, and Investments
2.3.3 New Product Launches and Approvals
2.4 Long-Term Outlook
CHAPTER 3 REGULATORY STRUCTURE: PHARMACEUTICAL DRUG MARKET
3.1 Regulatory Background
3.2 Regulatory Systems for Biopharmaceuticals by Region
3.2.1 U.S.
3.2.2 Europe
3.2.3 Japan
3.3 Regulatory Systems for Pharmaceuticals by Region
3.3.1 U.S.
3.3.2 Japan
3.3.3 India
3.3.4 Brazil
3.4 Regulations for Vaccines
3.4.1 Current Regulatory Issues for Vaccines
3.4.2 Moderna Vaccine Regulation in the U.K.
3.5 Key Regulatory Updates 2021
3.5.1 Pharmaceuticals
3.5.2 Medical Devices
3.6 Code of Federal Regulations (CFR)
3.7 Good Manufacturing Practice (GMP) Compliance
3.8 Establishment Registration
3.9 Drug Registration and Listing
3.10 Local Agent Requirements
3.10.1 Responsibilities of the U.S. agent
CHAPTER 4 PRICING AND REIMBURSEMENT: PHARMACEUTICALS AND BIOLOGICS
4.1 Pricing and Reimbursement Background
4.2 Pricing and Reimbursement of Pharmaceuticals and Biologics by Region
4.2.1 U.S.
4.2.2 Europe
4.2.3 Japan
4.3 Pricing and Reimbursement Challenges for Pharmaceuticals
4.3.1 Patented Medicines Price
4.3.2 Prices of Older Drugs
CHAPTER 5 COMPANY PROFILES
ABBOTT
ABBVIE INC.
ALEXION PHARMACEUTICALS INC.
AMGEN INC.
ASTELLAS PHARMA INC.
ASTRAZENECA
ASAHI KASEI CORP.
AUROBINDO PHARMA
BAUSCH HEALTH COMPANIES INC.
BAYER AG
BIOGEN
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BRISTOL-MYERS SQUIBB CO.
CHUGAI PHARMACEUTICAL CO. LTD.
CSL LTD.
DAIICHI SANKYO CO. LTD.
DR. REDDY'S LABORATORIES LTD.
EISAI CO. LTD.
ELI LILLY AND CO.
ENDO INTERNATIONAL PLC
GILEAD SCIENCES INC.
GLAXOSMITHKLINE PLC
GRIFOLS S.A.
H. LUNDBECK A/S
INCYTE
IPSEN PHARMA
JOHNSON & JOHNSON SERVICES INC.
MALLINCKRODT PLC
A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L.
MERCK & CO. INC.
MERCK KGAA
MODERNA INC.
NOVARTIS AG
NOVO NORDISK A/S
OTSUKA HOLDINGS CO. LTD.
PFIZER INC.
REGENERON PHARMACEUTICALS INC.
F. HOFFMANN-LA ROCHE LTD. (ROCHE)
SANOFI
SERVIER LABORATORIES
SHANGHAI PHARMACEUTICALS HOLDING
SHIONOGI & CO. LTD.
CHINA NATIONAL PHARMACEUTICAL GROUP CORP. (SINOPHARM)
STADA ARZNEIMITTEL AG
SUMITOMO PHARMA CO. LTD
SUN PHARMACEUTICAL INDUSTRIES LTD.
TAKEDA PHARMACEUTICAL CO. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
UCB S.A.
VERTEX PHARMACEUTICALS INC.
VIATRIS INC.
ZYDUS CADILA
1.1 Study Goals and Objectives
1.2 Reasons for Doing This Study
1.3 Scope of Report
1.4 Methodology
1.4.1 Primary Data and Information Gathering
1.4.2 Secondary Data and Information Gathering
1.4.3 Market Revenue Forecasts
1.5 Analyst's Credentials
1.6 BCC Custom Research
1.7 Related BCC Research Reports
CHAPTER 2 GLOBAL PHARMACEUTICAL DRUG MARKET
2.1 Overview
2.2 Key Strategies of Major Pharmaceutical Drugs Manufacturers
2.2.1 Distribution Network
2.2.2 Trends
2.2.3 Mergers and Acquisitions
2.2.4 Recommendations
2.3 Key Developments of the Major Pharmaceutical Drugs Manufacturers
2.3.1 Mergers and Acquisitions
2.3.2 Agreements, Joint Ventures, Expansions, Divestments, and Investments
2.3.3 New Product Launches and Approvals
2.4 Long-Term Outlook
CHAPTER 3 REGULATORY STRUCTURE: PHARMACEUTICAL DRUG MARKET
3.1 Regulatory Background
3.2 Regulatory Systems for Biopharmaceuticals by Region
3.2.1 U.S.
3.2.2 Europe
3.2.3 Japan
3.3 Regulatory Systems for Pharmaceuticals by Region
3.3.1 U.S.
3.3.2 Japan
3.3.3 India
3.3.4 Brazil
3.4 Regulations for Vaccines
3.4.1 Current Regulatory Issues for Vaccines
3.4.2 Moderna Vaccine Regulation in the U.K.
3.5 Key Regulatory Updates 2021
3.5.1 Pharmaceuticals
3.5.2 Medical Devices
3.6 Code of Federal Regulations (CFR)
3.7 Good Manufacturing Practice (GMP) Compliance
3.8 Establishment Registration
3.9 Drug Registration and Listing
3.10 Local Agent Requirements
3.10.1 Responsibilities of the U.S. agent
CHAPTER 4 PRICING AND REIMBURSEMENT: PHARMACEUTICALS AND BIOLOGICS
4.1 Pricing and Reimbursement Background
4.2 Pricing and Reimbursement of Pharmaceuticals and Biologics by Region
4.2.1 U.S.
4.2.2 Europe
4.2.3 Japan
4.3 Pricing and Reimbursement Challenges for Pharmaceuticals
4.3.1 Patented Medicines Price
4.3.2 Prices of Older Drugs
CHAPTER 5 COMPANY PROFILES
ABBOTT
ABBVIE INC.
ALEXION PHARMACEUTICALS INC.
AMGEN INC.
ASTELLAS PHARMA INC.
ASTRAZENECA
ASAHI KASEI CORP.
AUROBINDO PHARMA
BAUSCH HEALTH COMPANIES INC.
BAYER AG
BIOGEN
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
BRISTOL-MYERS SQUIBB CO.
CHUGAI PHARMACEUTICAL CO. LTD.
CSL LTD.
DAIICHI SANKYO CO. LTD.
DR. REDDY'S LABORATORIES LTD.
EISAI CO. LTD.
ELI LILLY AND CO.
ENDO INTERNATIONAL PLC
GILEAD SCIENCES INC.
GLAXOSMITHKLINE PLC
GRIFOLS S.A.
H. LUNDBECK A/S
INCYTE
IPSEN PHARMA
JOHNSON & JOHNSON SERVICES INC.
MALLINCKRODT PLC
A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L.
MERCK & CO. INC.
MERCK KGAA
MODERNA INC.
NOVARTIS AG
NOVO NORDISK A/S
OTSUKA HOLDINGS CO. LTD.
PFIZER INC.
REGENERON PHARMACEUTICALS INC.
F. HOFFMANN-LA ROCHE LTD. (ROCHE)
SANOFI
SERVIER LABORATORIES
SHANGHAI PHARMACEUTICALS HOLDING
SHIONOGI & CO. LTD.
CHINA NATIONAL PHARMACEUTICAL GROUP CORP. (SINOPHARM)
STADA ARZNEIMITTEL AG
SUMITOMO PHARMA CO. LTD
SUN PHARMACEUTICAL INDUSTRIES LTD.
TAKEDA PHARMACEUTICAL CO. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
UCB S.A.
VERTEX PHARMACEUTICALS INC.
VIATRIS INC.
ZYDUS CADILA
LIST OF TABLES
Table 1: Global Pharmaceutical Drug Manufacturers Market and Share, 2021
Table 2: Global Pharmaceutical Drug Manufacturers: Key Financials 2021
Table 3: Global Pharmaceutical Drug Manufacturers R&D Expenditure and % of R&D in Revenue, by Company, 2021
Table 4: Top 50 Best-Selling Pharmaceuticals, 2021
Table 5: Newly Launched Top Drugs, by Revenue, 2019-2021
Table 6: Key Pharmaceutical Drugs Patent Expirations 2023-2026
Table 7: Global Market for Pharmaceutical Drugs, Through 2020
Table 8: Global Market for Pharmaceutical Drugs, Through 2027
Table 9: Global Market for Pharmaceutical Drugs, by Region, Through 2020
Table 10: Global Market for Pharmaceutical Drugs, by Region, Through 2027
Table 11: Countries/Region that Authorized Moderna’s Vaccine for COVID-19
Table 12: Standard Vaccine Pricing Process in the U.S.
Table 13: COVID-19 Vaccine Price Range in the U.S., by Federal Government Purchase, 2021
Table 14: Abbott: Financials, 2016-2021
Table 15: Abbott: Product Portfolio, by Business Segment 2021
Table 16: Abbott: Recent Developments, 2015-2020
Table 17: AbbVie Inc.: Oncology Pharmaceutical Product Portfolio
Table 18: AbbVie Inc.: Oncology Pharmaceutical Revenue, 2018-2020
Table 19: AbbVie Inc.: Marketed Products
Table 20: AbbVie Inc.: Business Segment
Table 21: AbbVie Inc.: Financial Performance, 2018-2021
Table 22: AbbVie Inc.: Key Developments, 2022
Table 23: Alexion: Financial Performance, 2020
Table 24: Alexion: Key Developments, 2022
Table 25: Amgen: Financial Performance, 2018-2021
Table 26: Amgen: Financials, 2014-2021
Table 27: Amgen: Oncology Pharmaceuticals Product Portfolio
Table 28: Amgen: Oncology Pharmaceuticals Revenue, 2018-2020
Table 29: Amgen: Key Developments, 2022
Table 30: Astellas: Key Financials 2021
Table 31: Astellas: Oncology Pharmaceuticals Product Portfolio
Table 32: Astellas: Oncology Pharmaceuticals Revenue, 2018-2020
Table 33: Astellas: Key Developments, 2022
Table 34: AstraZeneca: Financial Performance, 2018-2021
Table 35: AstraZeneca: Oncology Pharmaceuticals Product Portfolio
Table 36: AstraZeneca: Oncology Pharmaceuticals Revenue, 2018-2020
Table 37: Aurobindo Pharma: Financial Performance, 2021
Table 38: Bausch Health Companies Inc.: Product Portfolio of Dermatology Devices
Table 39: Bayer AG: Marketed Products
Table 40: Bayer AG: Oncology Pharmaceuticals Product Portfolio
Table 41: Bayer AG: Oncology Pharmaceuticals Revenue, 2018-2020
Table 42: Bayer AG: Key Financials, 2021
Table 43: Biogen: Key Financials, 2021
Table 44: Bristol-Myers Squibb: Financial Performance, 2018-2021
Table 45: Bristol-Myers Squibb: Oncology Pharmaceuticals Product Portfolio
Table 46: Bristol-Myers Squibb: Oncology Pharmaceuticals Revenue, 2018-2020
Table 47: CSL Ltd. (Seqirus): Vaccines Offered
Table 48: CSL Ltd. (Seqirus): Recent Developments, 2022
Table 49: Daiichi Sankyo Co. Ltd.: Net Revenue 2021
Table 50: Dr. Reddy’s: Key Financials 2021
Table 51: Eisai: Key Financials, 2021
Table 52: Eli Lilly and Co.: Business Segments
Table 53: Eli Lilly and Co.: Marketed Osteoporosis Products
Table 54: Eli Lilly and Co.: Financial Performance, 2018-2021
Table 55: Eli Lilly and Co.: Oncology Pharmaceuticals Product Portfolio
Table 56: Eli Lilly and Co.: Oncology Pharmaceuticals Revenue, 2018-2020
Table 57: Endo International: Key Financials, 2021
Table 58: Gilead Sciences Inc.: Oncology Pharmaceuticals Product Portfolio
Table 59: Gilead Sciences Inc.: Oncology Pharmaceuticals Revenue, 2018-2020
Table 60: Gilead Sciences Inc.: Key Financials, 2021
Table 61: GlaxoSmithKline plc: Product Segment
Table 62: GlaxoSmithKline plc: Key Financials, 2021
Table 63: GlaxoSmithKline plc: Vaccines Offered
Table 64: GlaxoSmithKline plc: Flu Vaccines Sales
Table 65: GlaxoSmithKline plc: Recent Developments, 2022
Table 66: Grifols S.A.: Product Portfolio
Table 67: Lundbeck: Key Financials, 2021
Table 68: Incyte: Key Financials, 2021
Table 69: Ipsen: Key Financials, 2021
Table 70: Johnson & Johnson: Business Segments
Table 71: Johnson & Johnson: Financials, 2021
Table 72: Johnson & Johnson: Financial Performance, 2018-2021
Table 73: Johnson & Johnson: Product Description
Table 74: Johnson & Johnson: Recent Developments and Strategies, 2022
Table 75: Mallinckrodt: Key Financials, 2021
Table 76: Menarini Group: Key Financials, 2021
Table 77: Merck & Co. Inc.: Business Segment
Table 78: Merck & Co. Inc.: Financial Performance, 2018-2021
Table 79: Merck KGaA: Key Financials, 2021
Table 80: Moderna: Key Financials, 2021
Table 81: Novartis: Oncology Pharmaceuticals Product Portfolio
Table 82: Novartis: Oncology Pharmaceuticals Revenue, 2018-2020
Table 83: Novartis: Key Financials, 2021
Table 84: Novartis Key Developments, 2022
Table 85: Novo Nordisk: Product Portfolio
Table 86: Novo Nordisk: Key Financials, 2021
Table 87: Otsuka Holdings Co. Ltd.: Key Financials, 2021
Table 88: Otsuka Holdings Co. Ltd.: Key Developments, 2022
Table 89: Pfizer Inc.: Product Segments
Table 90: Pfizer Inc.: Oncology Pharmaceuticals Product Portfolio
Table 91: Pfizer Inc.: Oncology Pharmaceuticals Revenue, 2018-2020
Table 92: Pfizer Inc.: Women’s Health-Marketed Products by Indication
Table 93: Pfizer Inc.: Key Financials, 2021
Table 94: Regeneron: Key Financials, 2021
Table 95: Roche: Business Segment
Table 96: Roche: Financials, 2021
Table 97: Roche: Financial Performance, 2018-2020
Table 98: Roche: Revenue, by Segment, 2016-2018
Table 99: Roche: Revenue, by Diagnostic Segment, 2016-2018
Table 100: Roche: Product Portfolio
Table 101: Roche: Diagnostics Patient Monitoring Product Portfolio
Table 102: Roche: Oncology Pharmaceuticals Product Portfolio
Table 103: Roche: Oncology Pharmaceuticals Revenue, 2018-2020
Table 104: Roche: Key Developments, 2022
Table 105: Sanofi: Business Segments
Table 106: Sanofi: Financial Performance, 2021
Table 107: Sanofi: Oncology Pharmaceuticals Product Portfolio
Table 108: Sanofi: Oncology Pharmaceuticals Revenue, 2018-2020
Table 109: Servier: Key Financials, 2021
Table 110: Shionogi: Key Financials, 2021
Table 111: Sinopharm: Key Financials, 2021
Table 112: Stada Arzneimittel: Key Financials, 2021
Table 113: Sumitomo Dainippon Pharma: Key Financials, 2021
Table 114: Sun Pharmaceutical: Key Financials, 2021
Table 115: Takeda: Oncology Pharmaceuticals Product Portfolio
Table 116: Takeda: Oncology Pharmaceuticals Revenue, 2019-2021
Table 117: Takeda: Key Financials, 2021
Table 118: Teva: Key Financials 2021
Table 119: UCB: Key Financials, 2021
Table 120: Vertex: Recent Developments, 2022
Table 121: Vertex: Key Financials, 2021
Table 122: Viatris: Top Product Portfolio
Table 123: Viatris: Key Financials, 2021
Table 124: Viatris: Key Developments, 2022
Table 1: Global Pharmaceutical Drug Manufacturers Market and Share, 2021
Table 2: Global Pharmaceutical Drug Manufacturers: Key Financials 2021
Table 3: Global Pharmaceutical Drug Manufacturers R&D Expenditure and % of R&D in Revenue, by Company, 2021
Table 4: Top 50 Best-Selling Pharmaceuticals, 2021
Table 5: Newly Launched Top Drugs, by Revenue, 2019-2021
Table 6: Key Pharmaceutical Drugs Patent Expirations 2023-2026
Table 7: Global Market for Pharmaceutical Drugs, Through 2020
Table 8: Global Market for Pharmaceutical Drugs, Through 2027
Table 9: Global Market for Pharmaceutical Drugs, by Region, Through 2020
Table 10: Global Market for Pharmaceutical Drugs, by Region, Through 2027
Table 11: Countries/Region that Authorized Moderna’s Vaccine for COVID-19
Table 12: Standard Vaccine Pricing Process in the U.S.
Table 13: COVID-19 Vaccine Price Range in the U.S., by Federal Government Purchase, 2021
Table 14: Abbott: Financials, 2016-2021
Table 15: Abbott: Product Portfolio, by Business Segment 2021
Table 16: Abbott: Recent Developments, 2015-2020
Table 17: AbbVie Inc.: Oncology Pharmaceutical Product Portfolio
Table 18: AbbVie Inc.: Oncology Pharmaceutical Revenue, 2018-2020
Table 19: AbbVie Inc.: Marketed Products
Table 20: AbbVie Inc.: Business Segment
Table 21: AbbVie Inc.: Financial Performance, 2018-2021
Table 22: AbbVie Inc.: Key Developments, 2022
Table 23: Alexion: Financial Performance, 2020
Table 24: Alexion: Key Developments, 2022
Table 25: Amgen: Financial Performance, 2018-2021
Table 26: Amgen: Financials, 2014-2021
Table 27: Amgen: Oncology Pharmaceuticals Product Portfolio
Table 28: Amgen: Oncology Pharmaceuticals Revenue, 2018-2020
Table 29: Amgen: Key Developments, 2022
Table 30: Astellas: Key Financials 2021
Table 31: Astellas: Oncology Pharmaceuticals Product Portfolio
Table 32: Astellas: Oncology Pharmaceuticals Revenue, 2018-2020
Table 33: Astellas: Key Developments, 2022
Table 34: AstraZeneca: Financial Performance, 2018-2021
Table 35: AstraZeneca: Oncology Pharmaceuticals Product Portfolio
Table 36: AstraZeneca: Oncology Pharmaceuticals Revenue, 2018-2020
Table 37: Aurobindo Pharma: Financial Performance, 2021
Table 38: Bausch Health Companies Inc.: Product Portfolio of Dermatology Devices
Table 39: Bayer AG: Marketed Products
Table 40: Bayer AG: Oncology Pharmaceuticals Product Portfolio
Table 41: Bayer AG: Oncology Pharmaceuticals Revenue, 2018-2020
Table 42: Bayer AG: Key Financials, 2021
Table 43: Biogen: Key Financials, 2021
Table 44: Bristol-Myers Squibb: Financial Performance, 2018-2021
Table 45: Bristol-Myers Squibb: Oncology Pharmaceuticals Product Portfolio
Table 46: Bristol-Myers Squibb: Oncology Pharmaceuticals Revenue, 2018-2020
Table 47: CSL Ltd. (Seqirus): Vaccines Offered
Table 48: CSL Ltd. (Seqirus): Recent Developments, 2022
Table 49: Daiichi Sankyo Co. Ltd.: Net Revenue 2021
Table 50: Dr. Reddy’s: Key Financials 2021
Table 51: Eisai: Key Financials, 2021
Table 52: Eli Lilly and Co.: Business Segments
Table 53: Eli Lilly and Co.: Marketed Osteoporosis Products
Table 54: Eli Lilly and Co.: Financial Performance, 2018-2021
Table 55: Eli Lilly and Co.: Oncology Pharmaceuticals Product Portfolio
Table 56: Eli Lilly and Co.: Oncology Pharmaceuticals Revenue, 2018-2020
Table 57: Endo International: Key Financials, 2021
Table 58: Gilead Sciences Inc.: Oncology Pharmaceuticals Product Portfolio
Table 59: Gilead Sciences Inc.: Oncology Pharmaceuticals Revenue, 2018-2020
Table 60: Gilead Sciences Inc.: Key Financials, 2021
Table 61: GlaxoSmithKline plc: Product Segment
Table 62: GlaxoSmithKline plc: Key Financials, 2021
Table 63: GlaxoSmithKline plc: Vaccines Offered
Table 64: GlaxoSmithKline plc: Flu Vaccines Sales
Table 65: GlaxoSmithKline plc: Recent Developments, 2022
Table 66: Grifols S.A.: Product Portfolio
Table 67: Lundbeck: Key Financials, 2021
Table 68: Incyte: Key Financials, 2021
Table 69: Ipsen: Key Financials, 2021
Table 70: Johnson & Johnson: Business Segments
Table 71: Johnson & Johnson: Financials, 2021
Table 72: Johnson & Johnson: Financial Performance, 2018-2021
Table 73: Johnson & Johnson: Product Description
Table 74: Johnson & Johnson: Recent Developments and Strategies, 2022
Table 75: Mallinckrodt: Key Financials, 2021
Table 76: Menarini Group: Key Financials, 2021
Table 77: Merck & Co. Inc.: Business Segment
Table 78: Merck & Co. Inc.: Financial Performance, 2018-2021
Table 79: Merck KGaA: Key Financials, 2021
Table 80: Moderna: Key Financials, 2021
Table 81: Novartis: Oncology Pharmaceuticals Product Portfolio
Table 82: Novartis: Oncology Pharmaceuticals Revenue, 2018-2020
Table 83: Novartis: Key Financials, 2021
Table 84: Novartis Key Developments, 2022
Table 85: Novo Nordisk: Product Portfolio
Table 86: Novo Nordisk: Key Financials, 2021
Table 87: Otsuka Holdings Co. Ltd.: Key Financials, 2021
Table 88: Otsuka Holdings Co. Ltd.: Key Developments, 2022
Table 89: Pfizer Inc.: Product Segments
Table 90: Pfizer Inc.: Oncology Pharmaceuticals Product Portfolio
Table 91: Pfizer Inc.: Oncology Pharmaceuticals Revenue, 2018-2020
Table 92: Pfizer Inc.: Women’s Health-Marketed Products by Indication
Table 93: Pfizer Inc.: Key Financials, 2021
Table 94: Regeneron: Key Financials, 2021
Table 95: Roche: Business Segment
Table 96: Roche: Financials, 2021
Table 97: Roche: Financial Performance, 2018-2020
Table 98: Roche: Revenue, by Segment, 2016-2018
Table 99: Roche: Revenue, by Diagnostic Segment, 2016-2018
Table 100: Roche: Product Portfolio
Table 101: Roche: Diagnostics Patient Monitoring Product Portfolio
Table 102: Roche: Oncology Pharmaceuticals Product Portfolio
Table 103: Roche: Oncology Pharmaceuticals Revenue, 2018-2020
Table 104: Roche: Key Developments, 2022
Table 105: Sanofi: Business Segments
Table 106: Sanofi: Financial Performance, 2021
Table 107: Sanofi: Oncology Pharmaceuticals Product Portfolio
Table 108: Sanofi: Oncology Pharmaceuticals Revenue, 2018-2020
Table 109: Servier: Key Financials, 2021
Table 110: Shionogi: Key Financials, 2021
Table 111: Sinopharm: Key Financials, 2021
Table 112: Stada Arzneimittel: Key Financials, 2021
Table 113: Sumitomo Dainippon Pharma: Key Financials, 2021
Table 114: Sun Pharmaceutical: Key Financials, 2021
Table 115: Takeda: Oncology Pharmaceuticals Product Portfolio
Table 116: Takeda: Oncology Pharmaceuticals Revenue, 2019-2021
Table 117: Takeda: Key Financials, 2021
Table 118: Teva: Key Financials 2021
Table 119: UCB: Key Financials, 2021
Table 120: Vertex: Recent Developments, 2022
Table 121: Vertex: Key Financials, 2021
Table 122: Viatris: Top Product Portfolio
Table 123: Viatris: Key Financials, 2021
Table 124: Viatris: Key Developments, 2022
LIST OF FIGURES
Figure 1: Global Company Market Shares of Pharmaceutical Drugs, 2021
Figure 2: Abbott: Revenue Share, by Region/Country, 2021
Figure 3: Abbott: Revenue Share, by Business Segment, 2021
Figure 4: Abbott: R&D Expenditure, 2015-2021
Figure 5: AbbVie Inc.: Hematologic Oncology Annual Revenue, 2018-2021
Figure 6: AbbVie Inc.: Net Revenue Share, by Business Segment, 2021
Figure 7: AbbVie Inc.: Net Revenue Share, by Region, 2021
Figure 8: AbbVie Inc.: Revenue Share, by Country, 2021
Figure 9: Alexion: Net Revenue Share, by Business Segment, 2020
Figure 10: Alexion: Net Revenue Share, by Region, 2020
Figure 11: Amgen: Oncology Pharmaceuticals Annual Revenue, 2018-2020
Figure 12: Amgen: Sales Share, by Product, 2021
Figure 13: Amgen: Revenue Share, by Region, 2021
Figure 14: Astellas: Oncology Pharmaceuticals Annual Revenue, 2018-2020
Figure 15: AstraZeneca: Sales Share, by Segment, 2021
Figure 16: AstraZeneca: Revenue Share, by Region, 2021
Figure 17: AstraZeneca: Oncology Pharmaceuticals Segment Annual Revenue, 2018-2021
Figure 18: Aurobindo Pharma: Net Revenue Share, by Region, 2021
Figure 19: Bausch Health Companies Inc.: Annual Revenue, 2017-2021
Figure 20: Bausch Health Companies Inc.: Revenue Share, by Segment, 2021
Figure 21: Bayer AG: Oncology Pharmaceuticals Annual Revenue, 2018-2020
Figure 22: Bayer AG: Oncology Pharmaceuticals Annual Revenue, 2018-2020
Figure 23: Bayer AG: Revenue Share, by Region, 2021
Figure 24: Bayer AG: Revenue Share, by Business Segment, 2021
Figure 25: Biogen: Sales Share, by Product, 2021
Figure 26: Biogen: Revenue Share, by Region, 2021
Figure 27: Boehringer Ingelheim: Annual Revenue, 2021
Figure 28: Boehringer Ingelheim: Revenue Share, by Business Segment, 2021
Figure 29: Boehringer Ingelheim: Revenue Share, by Region, 2021
Figure 30: Bristol-Myers Squibb: Sales Share, by Product, 2021
Figure 31: Bristol-Myers Squibb: Total Revenue Share, by Region, 2021
Figure 32: Bristol-Myers Squibb: Oncology Pharmaceuticals Annual Revenue, 2018-2020
Figure 33: CSL Ltd. (Seqirus): Net Revenue, 2017-2021
Figure 34: CSL Ltd.: Revenue Share, by Business Segment, 2021
Figure 35: Daiichi Sankyo Co. Ltd.: Revenue Share, by Business Segment, 2018
Figure 36: Dr. Reddy’s: Revenue Share, by Business Segment, 2021
Figure 37: Eli Lilly and Co.: Total Sales Share, by Product Segment, 2020
Figure 38: Eli Lilly and Co.: Revenue Share, by Product, 2020
Figure 39: Eli Lilly and Co.: Oncology Annual Revenue, 2018-2020
Figure 40: Eli Lilly and Co.: Total Revenue Share, by Region, 2020
Figure 41: Endo International: Revenue Share, by Business Segment, 2021
Figure 42: Endo International: Total Revenue Share, by Region, 2021
Figure 43: Gilead Sciences Inc.: Oncology Pharmaceuticals Annual Revenue, 2018-2020
Figure 44: Gilead Sciences Inc.: Revenue Share, by Business Segment, 2021
Figure 45: Gilead Sciences Inc.: Total Revenue Share, by Region, 2021
Figure 46: GlaxoSmithKline plc: Net Revenue, 2016-2021
Figure 47: GlaxoSmithKline plc: Revenue Share, by Business Segment, 2021
Figure 48: GlaxoSmithKline plc: Revenue Share, by Region, 2021
Figure 49: Grifols S.A.: Annual Revenue, 2018-2021
Figure 50: Grifols S.A.: Revenue Share, by Segment, 2021
Figure 51: Grifols S.A.: Revenue Share, by Region, 2021
Figure 52: Lundbeck: Revenue Share, by Business Segment, 2021
Figure 53: Lundbeck: Total Revenue Share, by Region, 2021
Figure 54: Incyte: Revenue Share, by Business Segment, 2021
Figure 55: Johnson & Johnson: Financials, 2017-2021
Figure 56: Johnson & Johnson: Total Sales Share, by Business Segment, 2021
Figure 57: Johnson & Johnson: Total Revenue Share, by Region, 2021
Figure 58: Mallinckrodt: Revenue Share, by Business Segment, 2021
Figure 59: Mallinckrodt: Total Revenue Share, by Region, 2021
Figure 60: Menarini Group: Revenue Share, by Business Segment, 2021
Figure 61: Menarini Group: Total Revenue Share, by Region, 2021
Figure 62: Merck & Co. Inc.: Revenue Share, by Business Segment, 2021
Figure 63: Merck & Co. Inc.: Revenue Share, by Region, 2021
Figure 64: Merck KGaA: Revenue Share, by Business Segment, 2021
Figure 65: Merck KGaA: Total Revenue Share, by Region, 2021
Figure 66: Novartis: Oncology Pharmaceuticals Segment Annual Revenue, 2018-2020
Figure 67: Novartis: Revenue Share, by Business Segment, 2021
Figure 68: Novartis: Total Revenue Share, by Region, 2021
Figure 69: Novo Nordisk: Revenue Share, by Region, 2021
Figure 70: Novo Nordisk: Revenue Share, by Business Segment, 2021
Figure 71: Otsuka Holdings Co. Ltd.: Annual Revenue, 2018-2021
Figure 72: Otsuka Holdings Co. Ltd.: Revenue Share, by Segment, 2020
Figure 73: Pfizer Inc.: Oncology Segment Annual Revenue, 2018-2020
Figure 74: Pfizer Inc.: Revenue Share, by Region, 2021
Figure 75: Pfizer Inc.: Revenue Share, by Business Segment, 2021
Figure 76: Regeneron: Revenue Share, by Business Segment, 2021
Figure 77: Roche: Revenue Share, by Segment, 2021
Figure 78: Roche: Total Sales Share, by Product Segment, 2020
Figure 79: Roche: Oncology Annual Revenue, 2018-2020
Figure 80: Sanofi: Net Sales Share, by Business Segment, 2021
Figure 81: Sanofi: Net Sales Share, by Region, 2021
Figure 82: Sanofi: Oncology Pharmaceuticals Annual Revenue, 2018-2020
Figure 83: Servier: Revenue Share, by Business Segment, 2021
Figure 84: Servier: Total Revenue Share, by Region, 2021
Figure 85: Stada Arzneimittel: Revenue Share, by Business Segment, 2021
Figure 86: Stada Arzneimittel: Total Revenue Share, by Region, 2021
Figure 87: Sumitomo Dainippon Pharma: Revenue Share, by Business Segment, 2021
Figure 88: Sun Pharmaceutical: Revenue Share, by Business Segment, 2021
Figure 89: Sun Pharmaceutical: Total Revenue Share, by Region, 2021
Figure 90: Takeda: Oncology Pharmaceuticals Annual Revenue, 2018-2020
Figure 91: Takeda: Revenue Share, by Business Segment, 2021
Figure 92: Takeda Pharmaceutical: Total Revenue Share, by Region, 2021
Figure 93: Teva: Annual Revenue, 2018-2020
Figure 94: Teva: Revenue Share, by Business Segment, 2021
Figure 95: Teva: Total Revenue Share, by Region, 2021
Figure 96: UCB: Revenue Share, by Business Segment, 2021
Figure 97: UCB: Total Revenue Share, by Region, 2021
Figure 98: Vertex: Revenue Share, by Business Segment, 2021
Figure 99: Vertex: Total Revenue Share, by Region, 2021
Figure 100: Viatris: Annual Revenue, 2018-2021
Figure 101: Viatris: Revenue Share, by Product Category, 2021
Figure 1: Global Company Market Shares of Pharmaceutical Drugs, 2021
Figure 2: Abbott: Revenue Share, by Region/Country, 2021
Figure 3: Abbott: Revenue Share, by Business Segment, 2021
Figure 4: Abbott: R&D Expenditure, 2015-2021
Figure 5: AbbVie Inc.: Hematologic Oncology Annual Revenue, 2018-2021
Figure 6: AbbVie Inc.: Net Revenue Share, by Business Segment, 2021
Figure 7: AbbVie Inc.: Net Revenue Share, by Region, 2021
Figure 8: AbbVie Inc.: Revenue Share, by Country, 2021
Figure 9: Alexion: Net Revenue Share, by Business Segment, 2020
Figure 10: Alexion: Net Revenue Share, by Region, 2020
Figure 11: Amgen: Oncology Pharmaceuticals Annual Revenue, 2018-2020
Figure 12: Amgen: Sales Share, by Product, 2021
Figure 13: Amgen: Revenue Share, by Region, 2021
Figure 14: Astellas: Oncology Pharmaceuticals Annual Revenue, 2018-2020
Figure 15: AstraZeneca: Sales Share, by Segment, 2021
Figure 16: AstraZeneca: Revenue Share, by Region, 2021
Figure 17: AstraZeneca: Oncology Pharmaceuticals Segment Annual Revenue, 2018-2021
Figure 18: Aurobindo Pharma: Net Revenue Share, by Region, 2021
Figure 19: Bausch Health Companies Inc.: Annual Revenue, 2017-2021
Figure 20: Bausch Health Companies Inc.: Revenue Share, by Segment, 2021
Figure 21: Bayer AG: Oncology Pharmaceuticals Annual Revenue, 2018-2020
Figure 22: Bayer AG: Oncology Pharmaceuticals Annual Revenue, 2018-2020
Figure 23: Bayer AG: Revenue Share, by Region, 2021
Figure 24: Bayer AG: Revenue Share, by Business Segment, 2021
Figure 25: Biogen: Sales Share, by Product, 2021
Figure 26: Biogen: Revenue Share, by Region, 2021
Figure 27: Boehringer Ingelheim: Annual Revenue, 2021
Figure 28: Boehringer Ingelheim: Revenue Share, by Business Segment, 2021
Figure 29: Boehringer Ingelheim: Revenue Share, by Region, 2021
Figure 30: Bristol-Myers Squibb: Sales Share, by Product, 2021
Figure 31: Bristol-Myers Squibb: Total Revenue Share, by Region, 2021
Figure 32: Bristol-Myers Squibb: Oncology Pharmaceuticals Annual Revenue, 2018-2020
Figure 33: CSL Ltd. (Seqirus): Net Revenue, 2017-2021
Figure 34: CSL Ltd.: Revenue Share, by Business Segment, 2021
Figure 35: Daiichi Sankyo Co. Ltd.: Revenue Share, by Business Segment, 2018
Figure 36: Dr. Reddy’s: Revenue Share, by Business Segment, 2021
Figure 37: Eli Lilly and Co.: Total Sales Share, by Product Segment, 2020
Figure 38: Eli Lilly and Co.: Revenue Share, by Product, 2020
Figure 39: Eli Lilly and Co.: Oncology Annual Revenue, 2018-2020
Figure 40: Eli Lilly and Co.: Total Revenue Share, by Region, 2020
Figure 41: Endo International: Revenue Share, by Business Segment, 2021
Figure 42: Endo International: Total Revenue Share, by Region, 2021
Figure 43: Gilead Sciences Inc.: Oncology Pharmaceuticals Annual Revenue, 2018-2020
Figure 44: Gilead Sciences Inc.: Revenue Share, by Business Segment, 2021
Figure 45: Gilead Sciences Inc.: Total Revenue Share, by Region, 2021
Figure 46: GlaxoSmithKline plc: Net Revenue, 2016-2021
Figure 47: GlaxoSmithKline plc: Revenue Share, by Business Segment, 2021
Figure 48: GlaxoSmithKline plc: Revenue Share, by Region, 2021
Figure 49: Grifols S.A.: Annual Revenue, 2018-2021
Figure 50: Grifols S.A.: Revenue Share, by Segment, 2021
Figure 51: Grifols S.A.: Revenue Share, by Region, 2021
Figure 52: Lundbeck: Revenue Share, by Business Segment, 2021
Figure 53: Lundbeck: Total Revenue Share, by Region, 2021
Figure 54: Incyte: Revenue Share, by Business Segment, 2021
Figure 55: Johnson & Johnson: Financials, 2017-2021
Figure 56: Johnson & Johnson: Total Sales Share, by Business Segment, 2021
Figure 57: Johnson & Johnson: Total Revenue Share, by Region, 2021
Figure 58: Mallinckrodt: Revenue Share, by Business Segment, 2021
Figure 59: Mallinckrodt: Total Revenue Share, by Region, 2021
Figure 60: Menarini Group: Revenue Share, by Business Segment, 2021
Figure 61: Menarini Group: Total Revenue Share, by Region, 2021
Figure 62: Merck & Co. Inc.: Revenue Share, by Business Segment, 2021
Figure 63: Merck & Co. Inc.: Revenue Share, by Region, 2021
Figure 64: Merck KGaA: Revenue Share, by Business Segment, 2021
Figure 65: Merck KGaA: Total Revenue Share, by Region, 2021
Figure 66: Novartis: Oncology Pharmaceuticals Segment Annual Revenue, 2018-2020
Figure 67: Novartis: Revenue Share, by Business Segment, 2021
Figure 68: Novartis: Total Revenue Share, by Region, 2021
Figure 69: Novo Nordisk: Revenue Share, by Region, 2021
Figure 70: Novo Nordisk: Revenue Share, by Business Segment, 2021
Figure 71: Otsuka Holdings Co. Ltd.: Annual Revenue, 2018-2021
Figure 72: Otsuka Holdings Co. Ltd.: Revenue Share, by Segment, 2020
Figure 73: Pfizer Inc.: Oncology Segment Annual Revenue, 2018-2020
Figure 74: Pfizer Inc.: Revenue Share, by Region, 2021
Figure 75: Pfizer Inc.: Revenue Share, by Business Segment, 2021
Figure 76: Regeneron: Revenue Share, by Business Segment, 2021
Figure 77: Roche: Revenue Share, by Segment, 2021
Figure 78: Roche: Total Sales Share, by Product Segment, 2020
Figure 79: Roche: Oncology Annual Revenue, 2018-2020
Figure 80: Sanofi: Net Sales Share, by Business Segment, 2021
Figure 81: Sanofi: Net Sales Share, by Region, 2021
Figure 82: Sanofi: Oncology Pharmaceuticals Annual Revenue, 2018-2020
Figure 83: Servier: Revenue Share, by Business Segment, 2021
Figure 84: Servier: Total Revenue Share, by Region, 2021
Figure 85: Stada Arzneimittel: Revenue Share, by Business Segment, 2021
Figure 86: Stada Arzneimittel: Total Revenue Share, by Region, 2021
Figure 87: Sumitomo Dainippon Pharma: Revenue Share, by Business Segment, 2021
Figure 88: Sun Pharmaceutical: Revenue Share, by Business Segment, 2021
Figure 89: Sun Pharmaceutical: Total Revenue Share, by Region, 2021
Figure 90: Takeda: Oncology Pharmaceuticals Annual Revenue, 2018-2020
Figure 91: Takeda: Revenue Share, by Business Segment, 2021
Figure 92: Takeda Pharmaceutical: Total Revenue Share, by Region, 2021
Figure 93: Teva: Annual Revenue, 2018-2020
Figure 94: Teva: Revenue Share, by Business Segment, 2021
Figure 95: Teva: Total Revenue Share, by Region, 2021
Figure 96: UCB: Revenue Share, by Business Segment, 2021
Figure 97: UCB: Total Revenue Share, by Region, 2021
Figure 98: Vertex: Revenue Share, by Business Segment, 2021
Figure 99: Vertex: Total Revenue Share, by Region, 2021
Figure 100: Viatris: Annual Revenue, 2018-2021
Figure 101: Viatris: Revenue Share, by Product Category, 2021
